Document is current
Any future updates will be listed below
-
Authors
Zhuang, Pan
Liu, Xiaohui
Jia, Wei
Zheng, Weifang
Wan, Xuzhi
Chen, Weiming
Gu, Jinping
Li, Yin
Lan, Xiaochun
Li, Haoyu
Tong, Wenzhou
Wu, Yuqi
Wu, Xiangming
Ao, Yang
Ye, Hao
Wu, Fei
Zhu, Li
Zhang, Lange
Li, Yaoran
Meng, Denghui
Tian, Yimei
Wang, Anli
Wu, Shanyun
Zhu, Fanghuan
Zhang, Yiju
Shi, Hongbo
Yu, Xiaomei
Zhang, Fan
Zhang, Yu
Jiao, Jingjing
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03708887 at ClinicalTrials.govDocuments that mention this clinical trial
Marine n-3 fatty acid treatment for carotid plaques in patients with type 2 diabetes
https://doi.org/10.1186/s12933-026-03082-7
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32202057)
National Natural Science Foundation of China (81773419)
Natural Science Foundation of Zhejiang Province (LY23C200007)
Young Elite Scientists Sponsorship Program by CAS (2022QNRC001)
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 6 January 2026
First Online: 20 January 2026
Declarations
:
: This trial was conducted in compliance with the Declaration of Helsinki and approved by the ethics committee for human research (reference no. 20180301) at Lanxi Red Cross Hospital in Jinhua, China. Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare that there is no conflict of interest.
